THE LATEST NEWS IN CANCER CLINICAL RESEARCH

Phergain Collaborators’ Ecosystem in Spain.

MEDSIR at ASCO 2023

Gema Llorente, new corporate CFO of MEDSIR

Rosario Rodríguez, New Chief Trial Officer at MEDSIR

New collaboration between MEDSIR and Dana Farber

Strategic partnership with REVEAL GENOMICS for cancer research

Jyoti Mundra, PhD, appointed as new Chief Business Officer at MEDSIR

MEDSIR and Oncoclínicas sign strategic alliance

MEDSIR signs a strategic alliance with Oncoclínicas to strengthen its international expansion

PATHFINDER Study (breast)

PARSIFAL Study (breast)

COPERNICO (Covid-19)

ABIGAIL Study (breast)

ZZFIRST Study (prostate)

PHENOMENAL Study (breast)

DEBBRAH Study (breast)

Joining forces with QUADRAM Institute Bioscience and University of Bristol for the project CALADRIO

PHERGain Study (breast)

CAILA Study (breast)

ORPHEUS Study (penile)